CHANDAN — Chandan Healthcare Income Statement
0.000.00%
- IN₹4.94bn
- IN₹5.40bn
- IN₹2.30bn
- 31
- 36
- 81
- 48
Annual income statement for Chandan Healthcare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PRESS |
Standards: | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 1,196 | 1,369 | 1,766 | 2,301 |
Cost of Revenue | ||||
Gross Profit | 558 | 704 | 936 | 1,225 |
Selling / General / Administrative Expenses | ||||
Depreciation and Amortization | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 1,193 | 1,296 | 1,537 | 1,955 |
Operating Profit | 2.94 | 72.9 | 229 | 346 |
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | -10.6 | 50.1 | 215 | 321 |
Provision for Income Taxes | ||||
Net Income After Taxes | -10.9 | 35.9 | 164 | 235 |
Minority Interest | ||||
Net Income Before Extraordinary Items | ||||
Net Income | -11.1 | 33.7 | 163 | 222 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | -11.1 | 33.7 | 163 | 222 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -0.454 | 1.38 | 6.66 | 10.8 |